181 related articles for article (PubMed ID: 31524376)
21. Mass spectral characterization of dichloroacetic acid-modified human glutathione transferase zeta.
Anderson WB; Liebler DC; Board PG; Anders MW
Chem Res Toxicol; 2002 Nov; 15(11):1387-97. PubMed ID: 12437329
[TBL] [Abstract][Full Text] [Related]
22. Perturbation of maleylacetoacetic acid metabolism in rats with dichloroacetic Acid-induced glutathione transferase zeta deficiency.
Lantum HB; Cornejo J; Pierce RH; Anders MW
Toxicol Sci; 2003 Jul; 74(1):192-202. PubMed ID: 12730618
[TBL] [Abstract][Full Text] [Related]
23. The influence of human GSTZ1 gene haplotype variations on GSTZ1 expression.
Langaee TY; Zhong G; Li W; Hamadeh I; Solayman MH; McDonough CW; Stacpoole PW; James MO
Pharmacogenet Genomics; 2015 May; 25(5):239-45. PubMed ID: 25738370
[TBL] [Abstract][Full Text] [Related]
24. GSTZ1 expression and chloride concentrations modulate sensitivity of cancer cells to dichloroacetate.
Jahn SC; Solayman MH; Lorenzo RJ; Langaee T; Stacpoole PW; James MO
Biochim Biophys Acta; 2016 Jun; 1860(6):1202-10. PubMed ID: 26850694
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate.
Tzeng HF; Blackburn AC; Board PG; Anders MW
Chem Res Toxicol; 2000 Apr; 13(4):231-6. PubMed ID: 10775321
[TBL] [Abstract][Full Text] [Related]
26. Age-dependent kinetics and metabolism of dichloroacetate: possible relevance to toxicity.
Shroads AL; Guo X; Dixit V; Liu HP; James MO; Stacpoole PW
J Pharmacol Exp Ther; 2008 Mar; 324(3):1163-71. PubMed ID: 18096758
[TBL] [Abstract][Full Text] [Related]
27. A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats.
Jiang Y; Milavetz G; James MO; An G
J Pharm Sci; 2017 May; 106(5):1396-1404. PubMed ID: 28163135
[TBL] [Abstract][Full Text] [Related]
28. Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans.
Shroads AL; Coats BS; Langaee T; Shuster JJ; Stacpoole PW
Drug Metab Pers Ther; 2015 Mar; 30(1):49-55. PubMed ID: 25283137
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity.
Cornett R; James MO; Henderson GN; Cheung J; Shroads AL; Stacpoole PW
Biochem Biophys Res Commun; 1999 Sep; 262(3):752-6. PubMed ID: 10471397
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of oral dichloroacetate in dogs.
Maisenbacher HW; Shroads AL; Zhong G; Daigle AD; Abdelmalak MM; Samper IS; Mincey BD; James MO; Stacpoole PW
J Biochem Mol Toxicol; 2013 Dec; 27(12):522-5. PubMed ID: 24038869
[TBL] [Abstract][Full Text] [Related]
31. Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate.
Shroads AL; Langaee T; Coats BS; Kurtz TL; Bullock JR; Weithorn D; Gong Y; Wagner DA; Ostrov DA; Johnson JA; Stacpoole PW
J Clin Pharmacol; 2012 Jun; 52(6):837-49. PubMed ID: 21642471
[TBL] [Abstract][Full Text] [Related]
32. Clinical physiology and pharmacology of GSTZ1/MAAI.
Stacpoole PW
Biochem Pharmacol; 2023 Nov; 217():115818. PubMed ID: 37742772
[TBL] [Abstract][Full Text] [Related]
33. Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid.
Tong Z; Board PG; Anders MW
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):371-4. PubMed ID: 9531472
[TBL] [Abstract][Full Text] [Related]
34. Nephrotoxicity of chlorofluoroacetic acid in rats.
Lantum HB; Baggs RB; Krenitsky DM; Anders MW
Toxicol Sci; 2002 Dec; 70(2):261-8. PubMed ID: 12441371
[TBL] [Abstract][Full Text] [Related]
35. Glutathione transferase zeta: discovery, polymorphic variants, catalysis, inactivation, and properties of Gstz1-/- mice.
Board PG; Anders MW
Drug Metab Rev; 2011 May; 43(2):215-25. PubMed ID: 21303221
[TBL] [Abstract][Full Text] [Related]
36. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.
Saghir SA; Schultz IR
Environ Health Perspect; 2002 Aug; 110(8):757-63. PubMed ID: 12153755
[TBL] [Abstract][Full Text] [Related]
37. Phenylalanine-induced leucopenia in genetic and dichloroacetic acid generated deficiency of glutathione transferase Zeta.
Theodoratos A; Tu WJ; Cappello J; Blackburn AC; Matthaei K; Board PG
Biochem Pharmacol; 2009 Apr; 77(8):1358-63. PubMed ID: 19426674
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic or genetic ablation of maleylacetoacetate isomerase increases levels of toxic tyrosine catabolites in rodents.
Ammini CV; Fernandez-Canon J; Shroads AL; Cornett R; Cheung J; James MO; Henderson GN; Grompe M; Stacpoole PW
Biochem Pharmacol; 2003 Nov; 66(10):2029-38. PubMed ID: 14599561
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of the biotransformation of maleylacetone and chlorofluoroacetic acid by polymorphic variants of human glutathione transferase zeta (hGSTZ1-1).
Lantum HB; Board PG; Anders MW
Chem Res Toxicol; 2002 Jul; 15(7):957-63. PubMed ID: 12119007
[TBL] [Abstract][Full Text] [Related]
40. Human glutathione transferase zeta.
Board PG; Anders MW
Methods Enzymol; 2005; 401():61-77. PubMed ID: 16399379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
